At the heart of the stem cell community is the ISSCR Annual Meeting - a place where breakthrough science, global collaboration, and researchers across the breath of the field come together. The ISSCR Annual Meeting offers the best opportunity to collaborate with leaders and peers from around the...
Tisch MSRCNY is preparing for construction to commence January 2017 of a state-of-the-art stem cell facility on our 3rd floor. This could not have been done without the generosity of our supporters. The build-out of our new research laboratory enables Phase II of the Tisch MSRCNY FDA-approved stem...
Did you know you’re leaving valuable donations toward a Future Without MS on the table every time you shop on Amazon without connecting to Amazon Smile? What is AmazonSmile? AmazonSmile is a simple and automatic way for you to support the Tisch MS Research Center at no cost to you. When you log on...
Stars Come Out to Help End Multiple Sclerosis at Tisch MS Research Center of New York’s Future Without MS Gala New York, NY- November 1, 2016- The Tisch MS Research Center of New York (Tisch MSRCNY) announced today that their continued efforts to raise $10 million for the Center’s unprecedented...
The following article describes the first clinical use of of intrathecal MSC-NPs in 6 patients with progressive MS. An average followup of 7 years demonstrated both short and long term safety of the treatment. Four of the six patients showed a measurable clinical improvement following MSC-NP...
Like many of you, weare also very excited by the Chan Zuckerberg Initiative announcement. Here’s what we know so far: Rather than funding direct cures, the initiative will fund basic science research, asking questions like how cells divide or how proteins fold. The expectation is that answers to...
Tisch MSRCNY is excited to announce that as of September 14, 2016, all 20 patients in our FDA approved Phase I stem cell clinical trial have received their final treatment! Results will be analyzed and presented at our annual patient symposium on October 16th, 2016 at the New York Hilton Midtown...
New York, NY - January 13, 2016 - Tisch MS Research Center of New York (Tisch MSRCNY) announced today that it will pursue Phase II of its clinical trial, the first stem cell treatment for MS in the United States ever to move to this stage. Following the establishment of safety and tolerability in...